About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT03565263

Functional Gastrointestinal Disorders in Pediatric IBD

Background: Persistent gastrointestinal symptoms have been described in patients who are considered in remission of their inflammatory bowel disease (IBD). These symptoms, attributed to Functional gas...

Lead sponsor: University Hospital, Caen•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University Hospital, Caen

Age

9 - 18 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•IBD (Crohns disease, Ulcerative colitis or IBD-U)
•in remission (defined as: Physician's global assessment = remission, no nocturnal stools, no blood in stools, \< or = 3 stools/day, C reactive protein \< 10 mg/L, erythrocyte sedimentation rate \< 20 mm, no flare of disease or change of treatment in the last 3 months, no ongoing corticosteroid therapy
•followed for IBD for at least 1 year

Exclusion Criteria

•presence of an ileostomy or colostomy
•past history of total colectomy
•unable to understand written French or to answer the questionnaires

Related studies

Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings

NCT06934525 · Obsessive Compulsive Disorder (OCD), Pediatric Anxiety Disorders, and more

RECRUITINGPhase 3

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

NCT04844606 · Ulcerative Colitis, Ulcerative Colitis Chronic, and more

Acupuncture Reduces Relapse in Patients With Crohn's Disease: a Superiority Trial

NCT06553053 · Crohn's Disease Relapse, Inflammatory Bowel Diseases

RECRUITINGPhase 2

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

NCT06226883 · Inflammatory Bowel Diseases, Crohn's Disease

RECRUITINGPhase 2/3

Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease

NCT05986136 · Inflammatory Bowel Diseases

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 17, 2020Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment350

Start dateApr 2018

Last updatedNov 17, 2020

Condition

Inflammatory Bowel Diseases Functional Gastrointestinal Disorders Pediatric Disorder Anxiety Depression Quality of Life

Locations shown

Caen University Hospital

Caen

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 17, 2020Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions